Advances in biocatalytic synthesis of pharmaceutical intermediates.
Curr Opin Chem Biol
; 9(2): 188-94, 2005 Apr.
Article
en En
| MEDLINE
| ID: mdl-15811804
ABSTRACT
Biocatalytic synthesis of enantiomerically pure compounds for pharmaceutical intermediates is gaining momentum. This is the result of advances in genomics, screening and evolution technologies leading to the increased availability of new and robust biocatalysts suited for industrial-scale application, and is stimulated by an increased demand for catalysts that are able to address the increased complexity of active pharmaceutical ingredients. The vast majority of biotransformation reactions for the manufacturing of optically active pharmaceutical intermediates are still based on enantioselective ketone reductions and enantiospecific hydrolyses. This review aims to point at alternative reaction types and integrated multi-enzymatic steps that are emerging in large-scale applications.
Search on Google
Banco de datos:
MEDLINE
Asunto principal:
Biotecnología
/
Preparaciones Farmacéuticas
/
Enzimas
Idioma:
En
Año:
2005
Tipo del documento:
Article